Hide Board Information

Show Board Information

Volcan Compania Minera Sa VLCNF

Board Mod: Add me as mod

Asst Mods:

Last Post: 02/04/2025 10:14:20 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Volcan Compania Minera Sa (OTCMRKTS: VLCNF) Stock Message Board

1. VLCNF Company Profile

    

2. VLCNF Time & Sales

    

3. VLCNF Recent News

    

4. VLCNF Filings

    

5. VLCNF Financials

    

6. VLCNF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	$VLCN Hod10.1 Halt fest F560,902 Only S@8.5 then	znewcar1	02/04/2025 10:14:20 AM
6	LOD2.52 20dma@2.35 hodl?	znewcar1	09/06/2022 9:52:51 AM
5	VLCN 13% v3M $3.00 f24,3M HOD3.15 getting	znewcar1	08/30/2022 1:52:12 PM
4	66 views HOD3.03 VLCN huge vol	znewcar1	08/30/2022 12:55:00 PM
3	VLCN 6% v1,06 $2.799 double tap @1.8 now pushing (1)	znewcar1	08/30/2022 11:32:56 AM
2	VLCN 40% v54,9M c2.24 f24,3M H2.57	znewcar1	07/11/2022 4:17:58 PM
1	VLCN 97% v7,0M c10.86 f? H15.5	znewcar1	10/06/2021 4:03:56 PM

Recent Articles

• Codis Revolutionizes Spray Drying with New Global CDMO Services
• Ericsson's Impressive Q3 2025 Financial Performance Unveiled
• Exploring the Rapid Growth of the Global Smartwatch Market
• Helvetic Broker’s New Apps Simplify Crypto Management Effortlessly
• Pulsar Helium's Exciting Drilling Campaign at Topaz Project
• ING's Share Buyback Program: Key Updates and Insights
• Insightful Share Buyback: NB Private Equity Partners Update
• JDE Peet’s Launches Enhanced Innovation Lab to Advance Coffee Taste
• Elis Announces Its Recent Share Buyback Activities
• Equinor ASA's Enhanced Share Buyback Strategy Details
• Discover Rugged Computing Solutions at Logistik & Transport
• Foresight Group Engages in Share Buyback for Growth Strategy
• AEI Reveals September 2025 NAV and Solar Developments Ahead
• VINCI's Recent Share Buyback Activity Overview
• Sampo plc's Recent Share Buyback: Key Highlights Unveiled
• Breakthrough Outcomes of Telitacicept in Sjögren's Syndrome Study
• Republic Power Group's Initial Public Offering Unveiled
• Publicis Groupe Shows Impressive 5.7% Organic Growth in Q3 2025
• Serabi Gold Celebrates Record Production of Gold Ounces
• Publicis Groupe Reports Impressive Third Quarter Growth
• Ericsson and Vodafone Unveil Ambitious Network Partnership
• Transforming Connectivity: Ericsson and Vodafone's Bold Partnership
• ASUS Launches Revolutionary AI Solutions for Enterprises
• Moomoo Emerges as Australia's Leading Trading App in Downloads
• Leqembi Iqlik Recognized as a Leading Innovation of 2025
• Leqembi Iqlik™ Recognized as a Top Medical Innovation of 2025
• Arcadis Shares Buyback Initiatives Drive Corporate Strategy
• WISeKey Reports Strong Revenue Growth and Future Prospects
• DNO ASA's Q3 2025 Update: Production and Financial Insights
• dsm-firmenich Sees Steady Progress in Share Buyback Program
• Memecoin Surge: Shiba Inu and Pepe Lead the Charge
• ASUS Leads in AI Solutions with Innovative NVIDIA Technologies
• DHT Holdings, Inc. Provides Insight into Financial Progress
• How the Crypto Market is Impacting Gold Prices Today
• Apple's iPhone Air Preorders Begin as eSIM Services Launch
• Lodha's Recognition as a Trusted Company Escalates Its Prestige
• Lodha's Achievement in Global Trust Recognition Highlights Values
• Howard Marks Analyzes Current Market Valuations and Trends
• ADI Foundation's Bold Mission: Bridging Global Digital Gaps
• BenQ's New Monitors Enhance Creativity for Mac Users
• U.S. Lumber Coalition Celebrates Trade Law Enforcement Gains
• Airties Launches Nova: A New Era for Connectivity Testing
• Dr. James Petros Unveils OrthoGen Health: A New Era in Healing
• Marketing Maven Secures Spot Among Nation's Elite PR Agencies
• Vacca Family Law Group Enhances Support for Peaceful Divorce
• Dow Inc. Investors Urged to Act in Upcoming Securities Case
• Adlai Nortye to Showcase Innovative Cancer Therapy at Key Conference
• Understanding Shareholder Rights and Legal Options for Investors
• Investigation Into Shareholder Rights for Companies in Transition
• Adlai Nortye's Pioneering Cancer Therapy Presentation at Key Conference